The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 429.00
Bid: 428.00
Ask: 430.50
Change: -0.50 (-0.12%)
Spread: 2.50 (0.584%)
Open: 430.00
High: 433.00
Low: 428.50
Prev. Close: 429.50
STEM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY24 Q1 Trading Update

19 Mar 2024 07:00

RNS Number : 3060H
SThree plc
19 March 2024
 

 

19 March 2024

 

SThree plc

 

FY24 Q1 Trading Update

 

 Resilient performance underpinned by continued strong contract extensions

 

SThree plc ("SThree" or the "Group"), the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), today issues a trading update covering the period 1 December 2023 to 29 February 2024.

 

Highlights

 

·

Group net fees for FY24 Q1 down 6% YoY(1) against a record prior year performance(2) and the ongoing challenging backdrop, with Contract (now 84% of net fees) down 2%.

·

Contractor order book(3) down 1% YoY to £184 million, representing sector-leading visibility with the equivalent of c.4 months of net fees.

·

Strong balance sheet with net cash of £97 million at 29 February 2024 (28 February 2023: £64 million).

·

Technology Improvement Programme remains on budget and on plan, with half of our cities in Germany initiated.

·

Performance for FY24 currently expected to be in line with market expectations(4).

 

Timo Lehne, Chief Executive, commented:

 

"Once again, we have delivered a good performance against a strong comparative and within a market environment that remains difficult from a new business perspective. Whilst the sentiment we are reporting is much the same as the prior period, the strength of our Contract extensions continues to be a particular highlight, demonstrating our clients' need to retain critical STEM skills and flexible talent.

 

We continue to make good progress with our Technology Improvement Programme, with our new end-to-end integrated platform now fully deployed in the US and initiated in Germany, providing our teams with the digital tools which will be key to driving both scale and higher margins over the mid-to-long term. 

 

Whilst we look forward to the easing of the macro environment, our strategic focus, exposure to long-term megatrends, and progress to date delivering operational enhancements provide us with a resilient and financially robust foundation with the capacity and improved capabilities to deliver our ambitions and future growth."

 

 

Business performance highlights

 

The Group delivered a good net fee performance in the quarter against the backdrop of a record prior year performance and tough market conditions, with net fees down 6% YoY driven by continued softness in new business across Contract and Permanent, which was largely offset by strong Contract extensions.

 

Across both Contract and Permanent, the Group saw continued strong demand for Engineering roles, driven primarily by the Energy sector with renewables the fastest growing segment, while demand for Life Sciences and Technology roles continues to reflect ongoing market conditions and record comparatives for Technology.

 

Regionally, the Group saw strong growth in the Middle East and Asia, driven by exceptional performance in Japan across all three of our main skill verticals. Within the Group's largest three markets, which represent 72% of net fees, the Netherlands achieved solid YoY growth due to strong Engineering and resilient Technology performances, while the USA was down, driven by declines in Life Sciences and Technology partially offset by an improving Engineering performance, and Germany was also down in spite of Engineering and Life Sciences growth, as the decline in Technology outweighed this performance.

 

As the Group remains focused on being positioned to respond as the market changes, average headcount for the quarter was down 12% YoY, whilst Group period-end headcount was flat versus FY23 Q4. Productivity(5) remains elevated above pre-pandemic levels achieved in FY19.

 

 

 

 

Q1

Q1

Q1 2024

 

Q4 2023

Q3 2023

Q2 2023

Q1 2023

 

Net fees

2024

2023

YoY (1)

 

YoY (1)

YoY (1)

YoY (1)

YoY (1)

 

Contract

£78.9m

£82.7m

-2%

-2%

-

-1%

+8%

 

Permanent

£14.8m

£19.9m

-21%

-17%

-31%

-25%

-12%

 

GROUP

£93.7m

£102.6m

-6%

 

-5%

-7%

-7%

+4%

 

 

 

 

 

 

 

 

 

 

 

Regions

 

DACH (6)

£31.5m

£36.8m

-13%

-5%

-6%

-7%

+8%

 

Netherlands (incl. Spain) (7)

£19.8m

£18.7m

+8%

+5%

+9%

+4%

+6%

 

Rest of Europe (8)

£15.6m

£17.5m

-10%

-8%

-5%

-7%

+4%

 

USA

£21.1m

£24.3m

-10%

-14%

-19%

-15%

-6%

 

Middle East & Asia (9)

£5.7m

£5.3m

+20%

+16%

-14%

-5%

+19%

 

GROUP

£93.7m

£102.6m

-6%

 

-5%

-7%

-7%

+4%

 

 

 

 

 

 

 

 

 

 

 

Top five countries

 

Germany

£27.6m

£32.7m

-14%

-6%

-6%

-8%

+7%

 

Netherlands

£18.4m

£17.9m

+6%

+2%

+5%

+1%

+4%

 

UK

£10.0m

£10.8m

-7%

-8%

-4%

-6%

+6%

 

USA

£21.1m

£24.3m

-10%

-14%

-19%

-15%

-6%

 

Japan

£2.5m

£2.1m

+41%

+24%

-4%

-2%

+7%

 

ROW (10)

£14.1m

£14.8m

-4%

+4%

-5%

-2%

+12%

 

Group

£93.7m

£102.6m

-6%

 

-5%

-7%

-7%

+4%

 

 

Service mix

Q1 2024

Q1 2023

 

 

 

 

 

Contract

84%

81%

 

 

 

Permanent

 16%

 19%

 

 

 

 

 

 

Skills mix

Q1 2024

Q1 2023

 

 

 

 

 

Technology

47%

49%

 

 

 

Life Sciences

16%

19%

 

 

 

Engineering

29%

24%

 

 

 

Other

8%

8%

 

 

 

 

 

(1) All YoY growth rates expressed at constant currency.

(2) FY23 Q1 Group Net Fees up 4% YoY to £102.6m.

(3) The contractor order book represents value of net fees until contractual end dates, assuming all contractual hours are worked.

(4) Current consensus PBT expectation is £71.9m for FY24. Source: SThree compiled consensus.

(5) Productivity calculated as net fees divided by total average headcount.

(6) DACH - Germany, Austria and Switzerland.

(7) Netherlands (incl. Spain) - Netherlands and Spain, which is managed from the Netherlands.

(8) Rest of Europe - UK, Belgium, France, Luxembourg and Ireland.

(9) Middle East & Asia - Japan, UAE & Singapore.

(10) ROW - All other countries we operate in.

 

 

Analyst conference call

 

SThree is hosting a conference call for analysts and investors today at 8.30am to discuss the FY24 Q1 Trading Update. If you would like to register for the conference call, please contact SThree@almastrategic.com.

The Group will issue its trading update for the six months ended 31 May 2024 on 18 June 2024.

 

 

 

 

Enquiries:

 

 

 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), providing permanent and flexible contract talent to a diverse base of over 7,200 clients across 11 countries. Our Group's c.2,700 staff cover the Technology, Life Sciences and Engineering sectors. SThree is part of the Industrial Services sector. We are listed on the Premium Segment of the London Stock Exchange's Main Market, trading with ticker code STEM.

 

Important notice

Certain statements in this announcement are forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Certain data from the announcement is sourced from unaudited internal management information and is before any exceptional items. Accordingly, undue reliance should not be placed on forward looking statements.

 

 

 

 

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFWFWAELSEFD
Date   Source Headline
25th Apr 202411:44 amRNSResult of AGM
15th Apr 20243:48 pmRNSDirector/PDMR Shareholding
10th Apr 202412:14 pmRNSChange of Auditor
2nd Apr 202412:10 pmRNSDirectorate Change
22nd Mar 20244:29 pmRNSDirector/PDMR Shareholding
19th Mar 20243:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFY24 Q1 Trading Update
14th Mar 202412:11 pmRNSDirector/PDMR Shareholding
12th Mar 20243:59 pmRNSDirector/PDMR Shareholding
7th Mar 20249:20 amRNSDirector/PDMR Shareholding
4th Mar 202410:54 amRNSAnnual Financial Report
23rd Feb 20242:00 pmRNSBlock listing Interim Review
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
1st Feb 202410:20 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSFY23 Final Results
23rd Jan 20244:25 pmRNSChange of Registrar
15th Jan 20241:19 pmRNSDirector/PDMR Shareholding
18th Dec 20234:56 pmRNSDirector/PDMR Shareholding
14th Dec 202310:58 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFY23 Full Year Trading Update
8th Dec 20234:30 pmRNSDirectorate Change
1st Dec 20232:27 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAppointment of Joint Corporate Brokers
16th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20239:45 amRNSHolding(s) in Company
2nd Nov 20232:45 pmRNSTotal Voting Rights
16th Oct 20232:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:53 pmRNSTotal Voting Rights
20th Sep 20231:19 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFY23 Q3 Trading Update
13th Sep 202310:35 amRNSDirector/PDMR Shareholding
1st Sep 202312:17 pmRNSTotal Voting Rights
23rd Aug 202311:40 amRNSBlock listing Interim Review
16th Aug 20232:16 pmRNSDirector/PDMR Shareholding
15th Aug 20231:26 pmRNSHolding(s) in Company
1st Aug 20234:30 pmRNSTotal Voting Rights
25th Jul 20237:00 amRNSRESULTS FOR THE SIX MONTHS ENDED 31 MAY 2023
13th Jul 20234:43 pmRNSDirector/PDMR Shareholding
6th Jul 20235:10 pmRNSHolding(s) in Company
3rd Jul 202310:42 amRNSTotal Voting Rights
20th Jun 20234:53 pmRNSDirector/PDMR Shareholding
20th Jun 20237:00 amRNSFY23 Half Year Trading Update
13th Jun 202311:37 amRNSDirector/PDMR Shareholding
1st Jun 20233:49 pmRNSTotal Voting Rights
15th May 202311:48 amEQSSThree: DSH-Director/PDMR Shareholding*
2nd May 202310:13 amEQSSThree: TVR-Total Voting Rights
19th Apr 20233:41 pmEQSSThree: AGM-AGM Statement
18th Apr 20239:46 amEQSSThree: DSH-Director/PDMR Shareholding*
17th Apr 20234:34 pmEQSSThree: HOL-Holding(s) in Company*
12th Apr 20237:00 amEQSSThree: SBTi-verified net-zero target and 2022 Impact Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.